Marker may predict response to cancer immunotherapy

Abundance of protein galectin-9 in cancer patients is associated with poor response to immunotherapy

Marker may predict response to cancer immunotherapyUniversity of Alberta researchers have uncovered a link between the expression of the protein galectin-9 (gal-9) and whether a cancer patient will benefit from immunotherapy. The discovery could help inform physicians about which patients will likely respond to immunotherapy and lead to better treatment options. Immunotherapy or biological therapy is the treatment of disease by…

3-D bioprinting successfully used to create nose cartilage

Searching for a better solution to a clinical problem facing many patients with skin cancer

A team of University of Alberta researchers has discovered a way to use 3-D bioprinting technology to create custom-shaped cartilage for use in surgical procedures. The work aims to make it easier for surgeons to safely restore the features of skin cancer patients living with nasal cartilage defects after surgery. The researchers used a specially…

Nanomedicine used to provide better outcomes during chemotherapy

Nanomedicine used to provide better outcomes during chemotherapyA University of Alberta researcher is using nanotechnology to improve the effectiveness of chemotherapy treatments for cancer patients and reduce their side effects. Afsaneh Lavasanifar is a professor in the University of Alberta’s Faculty of Pharmacy & Pharmaceutical Sciences and an adjunct professor in the Department of Chemical and Medical Engineering. Her lab develops precision health solutions through nanomedicine,…

Innovative cancer therapy uses immune system to attack tumours

Re-engineers your immune system to target and attack cancer growing in your body

Innovative cancer therapy uses immune system to attack tumoursImagine if you could re-engineer your immune system to target and attack cancer growing in your body. A new clinical trial led by a clinician researcher at the University of Alberta is doing just that. Michael Chu, an assistant professor of oncology in the Faculty of Medicine & Dentistry, is leading a project to manufacture and…

Muscle wasting syndrome cause of many cancer-related deaths

Project delves into how one growth hormone contributes to the problem and whether drugs can stop it

Muscle wasting syndrome cause of many cancer-related deathsResearchers are looking for ways to prevent or slow cachexia, a muscle-wasting syndrome thought to cause up to a third of the 80,000 deaths related to cancer every year in Canada. By understanding the role of activin A, a growth factor that contributes to muscle wasting, the team hopes their lab research will eventually help…

Research may help to accurately diagnose prostate cancer severity

Could predict which men are at risk of developing an aggressive form of the disease

Research may help to accurately diagnose prostate cancer severityScientists at the University of Alberta are part of a new research project to develop innovative precision diagnostics that could predict which men with prostate cancer are at risk of developing an aggressive form of the disease. The researchers will use germline sequencing (sequencing of the genes a person is born with) to determine which…

Safer source of islet cells targeted for people with Type 1 diabetes

U of A researchers are harnessing AI to analyze patients’ own cells to create islet cells for transplant

Safer source of islet cells targeted for people with Type 1 diabetesUniversity of Alberta researchers are harnessing the power of artificial intelligence to find a safer, more personalized source of islet cells to treat Type 1 diabetes. The research project, a collaboration between the departments of surgery and computing science, aims to use AI to analyze images to speed up the process and reduce the need for human decision-making…

Alberta not-for-profit runs cancer clinical trials around the world

Building on game-changing breast cancer trials, TRIO now testing drugs for breast, lung, ovarian, liver and gastrointestinal cancer

Alberta not-for-profit runs cancer clinical trials around the worldA not-for-profit research group with University of Alberta roots is quietly taking its place in the major leagues of global cancer drug testing. When promising new cancer treatments are ready for trial in humans, researchers from around the world turn to Edmonton-based TRIO (Translational Research in Oncology) to run their clinical trials. “It may seem like…

Ultrasound has potential for treating pain after chemotherapy

There may soon be a new option available to people experiencing sensory pain after chemotherapy

Ultrasound has potential for treating pain after chemotherapyTherapeutic ultrasound was a tool in Janice Yurick’s treatment arsenal for 15 years. Yurick, a now-retired physical therapist and former manager of supportive care services at the Cross Cancer Institute in Edmonton, Alberta had more than two decades of experience in oncology rehabilitation. She used the technology with patients and saw results, despite no actual…

Grads strive to improve care for LGBTQ2SPIA+ cancer patients

National survey identifies potential issues and areas for improvement among radiation therapy professionals

Grads strive to improve care for LGBTQ2SPIA+ cancer patientsA new study led by a group of recently graduated radiation therapy students at the University of Alberta shows that many in the profession feel more training is needed to properly care for cancer patients in the lesbian, gay, bisexual, trans, queer, two-spirit, pansexual, intersex, asexual, plus (LGBTQ2SPIA+) community. The team – Samantha Chan, Samie…
1 2 3 5